Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis

Keyphrases

• Cost-effectiveness 100%
• Health Benefits 100%
• Vitamin D 100%
• Stage 5 Chronic Kidney Disease 100%
• 5′-end 83%
• End-stage Renal Disease 83%
• Cardiovascular Events 50%
• Patient Outcomes 33%
• Secondary Hyperparathyroidism 33%
• Vitamin D Treatment 33%
• Quality-adjusted Life Years 33%
• Vitamin D Deficiency 33%
• Chronic Kidney Disease Patients 33%
• Chronic Kidney Disease Stage 33%
• Cost Savings 16%
• Early Treatment 16%
• Health Care Costs 16%
• Markov Model 16%
• Economic Outcomes 16%
• Disease-specific Mortality 16%
• Causal Relationship 16%
• Optimal Timing 16%
• Therapy Outcome 16%
• Treatment Results 16%
• Hypercalcemia 16%
• Medicare 16%
• Chronic Kidney Disease 16%
• Cost-effectiveness Analysis 16%
• Total Annual Cost 16%
• Clinical Events 16%
• Life Cost 16%
• Treatment Timing 16%
• Kidney Disease Progression 16%
• Dominant Strategy 16%
• Nephrology 16%
• Timing of Therapy 16%

Medicine and Dentistry

• Cost-Effectiveness Analysis 100%
• Vitamin D 100%
• Chronic Kidney Disease 100%
• Health Care Cost 31%
• End Stage Renal Disease 31%
• Cardiovascular System 18%
• Secondary Hyperparathyroidism 12%
• Quality Adjusted Life Year 12%
• Decision Making 6%
• Disease Exacerbation 6%
• Medicare 6%
• Hypercalcaemia 6%
• Nephrology 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Vitamin D 100%
• Chronic Kidney Failure 100%
• End Stage Renal Disease 31%
• Secondary Hyperparathyroidism 12%
• Disease Exacerbation 6%
• Hypercalcaemia 6%